We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
U.S. small-cap stocks are finding it tough to get off the grounds. The capitalization underperformed the large U.S. stocks last year. Though pint-sized stocks kicked off 2020 on a decent note, the rally was short-lived and small caps slowly gave way to the large-cap counterparts. The S&P 500 is down 3.9% so far this year (as of Mar 4, 2020), while the small-cap ETF SPDR S&P 600 Small Cap ETF has lost 10.2%.
However, things may look up for small-cap stocks soon. We’ll tell you why.
Massive Fed Rate Cut
The Fed enacted an emergency rate cut of 50 bps on Mar 3 to contain the virus-led market rout and prevent any potential economic loss. Before this virus eruption, the Fed was confident about the U.S. economy.
Historically, small caps have beaten large caps when the U.S. central bank has slashed rates. Small caps put up an average a 12-month return of 27.9% after the Fed gets on an easing cycle, Jefferies data shows. Large caps, in the meanwhile, came up with an average gain of about 15% in that time, per an article published on CNBC.
Upbeat U.S. Economy Datapoints
Apart from the short-term blip caused by the virus-driven supply chain disruption, the U.S. economy is on a firm footing now. U.S. companies created more jobs than estimated in February. The ISM Manufacturing PMI for the United States fell to 50.1 in February of 2020 from 50.9 in January due to the virus issue. But manufacturing data remained in the expansion territory. Retail sales rose 0.3% sequentially in January 2020, slightly higher than a downwardly revised 0.2% increase in December. Existing home sales came above market expectations. Since small-cap stocks are more domestically-focused, these data should favor small-cap stocks.
Less Dependent on Virus-Induced Global Supply Shock
Since small-cap stocks have less dependence on international economies, disruptions in global supply chain caused by the coronavirus won’t hurt the segment much. Supply chain issues have been troubling large-cap companies more. Apple (AAPL - Free Report) , Alphabet (GOOGL - Free Report) and Microsoft (MSFT - Free Report) are trying to shift some hardware production from China – the epicenter of the virus – to places like Vietnam and Thailand.
Greenback Strength
The greenback has gained so far this year. Invesco DB US Dollar Index Bullish Fund (UUP - Free Report) is up 1.2% year to date (as of Mar 4, 2020). The rising dollar environment lowers the gains of large caps with substantial foreign exposure but favor small-cap companies.
Forward P/E Ratio Looks Decent
Small caps do have earnings weakness but valuation of the segment looks decent at the current level. The forward P/E ratio of the S&P 600 is 17.27x (as of Jan 31, 2020) versus 18.53x offered by the S&P 500.
Stock Picks
Against this backdrop, we highlight a few top-performing small-cap stocks of the past month (as of Mar 4, 2020). These stocks have a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
This Zacks Rank #2 clinical-stage company develops a range of oral recombinant vaccines based on its proprietary delivery platform. It has a market cap of $103.08 million.
Aduro Biotech Inc. — Up 35.7%
The Zacks Rank #1 development-stage biopharmaceutical company is focused on the development and commercialization of therapies for serious diseases. The stock has a market cap of $244.76 million.
Rite Aid Corporation — Up 34.9%
This Zacks Rank #1 U.S. retail drugstore provides pharmacy benefit management to nearly 1,900 clients and 3.4 million members. It has a market cap of $907.25 million.
Sharps Compliance Corp — Up 32.4%
The Zacks Rank #1 company is a leading provider of disposal solutions for small quantity generators of medical waste. It has a market cap of $97.54 million.
Telenav Inc. — Up 27.08%
This provider of location-based services, or LBS, including voice guided navigation on mobile phones, has a Zacks Rank #1. It has a market cap of $293.73 million.
Free: Zacks’ Single Best Stock Set to Double
Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.
Image: Bigstock
5 Reasons to Buy These Small-Cap Stocks Now
U.S. small-cap stocks are finding it tough to get off the grounds. The capitalization underperformed the large U.S. stocks last year. Though pint-sized stocks kicked off 2020 on a decent note, the rally was short-lived and small caps slowly gave way to the large-cap counterparts. The S&P 500 is down 3.9% so far this year (as of Mar 4, 2020), while the small-cap ETF SPDR S&P 600 Small Cap ETF has lost 10.2%.
However, things may look up for small-cap stocks soon. We’ll tell you why.
Massive Fed Rate Cut
The Fed enacted an emergency rate cut of 50 bps on Mar 3 to contain the virus-led market rout and prevent any potential economic loss. Before this virus eruption, the Fed was confident about the U.S. economy.
Historically, small caps have beaten large caps when the U.S. central bank has slashed rates. Small caps put up an average a 12-month return of 27.9% after the Fed gets on an easing cycle, Jefferies data shows. Large caps, in the meanwhile, came up with an average gain of about 15% in that time, per an article published on CNBC.
Upbeat U.S. Economy Datapoints
Apart from the short-term blip caused by the virus-driven supply chain disruption, the U.S. economy is on a firm footing now. U.S. companies created more jobs than estimated in February. The ISM Manufacturing PMI for the United States fell to 50.1 in February of 2020 from 50.9 in January due to the virus issue. But manufacturing data remained in the expansion territory. Retail sales rose 0.3% sequentially in January 2020, slightly higher than a downwardly revised 0.2% increase in December. Existing home sales came above market expectations. Since small-cap stocks are more domestically-focused, these data should favor small-cap stocks.
Less Dependent on Virus-Induced Global Supply Shock
Since small-cap stocks have less dependence on international economies, disruptions in global supply chain caused by the coronavirus won’t hurt the segment much. Supply chain issues have been troubling large-cap companies more. Apple (AAPL - Free Report) , Alphabet (GOOGL - Free Report) and Microsoft (MSFT - Free Report) are trying to shift some hardware production from China – the epicenter of the virus – to places like Vietnam and Thailand.
Greenback Strength
The greenback has gained so far this year. Invesco DB US Dollar Index Bullish Fund (UUP - Free Report) is up 1.2% year to date (as of Mar 4, 2020). The rising dollar environment lowers the gains of large caps with substantial foreign exposure but favor small-cap companies.
Forward P/E Ratio Looks Decent
Small caps do have earnings weakness but valuation of the segment looks decent at the current level. The forward P/E ratio of the S&P 600 is 17.27x (as of Jan 31, 2020) versus 18.53x offered by the S&P 500.
Stock Picks
Against this backdrop, we highlight a few top-performing small-cap stocks of the past month (as of Mar 4, 2020). These stocks have a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
VAXART INC. (VXRT - Free Report) — Up 83.1%
This Zacks Rank #2 clinical-stage company develops a range of oral recombinant vaccines based on its proprietary delivery platform. It has a market cap of $103.08 million.
Aduro Biotech Inc. — Up 35.7%
The Zacks Rank #1 development-stage biopharmaceutical company is focused on the development and commercialization of therapies for serious diseases. The stock has a market cap of $244.76 million.
Rite Aid Corporation — Up 34.9%
This Zacks Rank #1 U.S. retail drugstore provides pharmacy benefit management to nearly 1,900 clients and 3.4 million members. It has a market cap of $907.25 million.
Sharps Compliance Corp — Up 32.4%
The Zacks Rank #1 company is a leading provider of disposal solutions for small quantity generators of medical waste. It has a market cap of $97.54 million.
Telenav Inc. — Up 27.08%
This provider of location-based services, or LBS, including voice guided navigation on mobile phones, has a Zacks Rank #1. It has a market cap of $293.73 million.
Free: Zacks’ Single Best Stock Set to Double
Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.
See 5 Stocks Set to Double>>